Latest News and Press Releases

PARSIPPANY, NJ, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant...

Vietnam, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Vietnam is the first country in the world to routinely use an innovative method to diagnose tuberculosis (TB) using stool. The Simple One-Step Stool...

PARSIPPANY, NJ, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered into a...

October 15, 2021 Solution offers high quality imaging with multi-site, multi-disciplinary interoperability, artificial intelligence and Laboratory Information System integration, enhancing...

 ●Q2 Revenue of $11.2 Million Surpasses Q1 2021 as Company’s Highest Revenue Quarter  ●Company approaching EBITDA breakeven on Higher Clinical Volume, Revenue, Improved Gross Profit and Operating...

Philadelphia, PA, July 15, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, announced today that Lisa Agdern, executive director,...

Philadelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, is honored to be presenting at the upcoming DIA 2021 Global...

San Francisco, California, March 18, 2021 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an affiliate of US Capital Global, is offering to eligible investors an investment opportunity of up...

PARSIPPANY, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, today announced that on...

Parsippany, NJ, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG) announced today that it has executed a license agreement with Rutgers, The State University of New...